Kevin Bitterman
CIK 1591747 · last filed 2025-12-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.95M
Companies
4
Total Filings
39
Lifetime Open-Market Net
-$72.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IRON | Director | 14,013 | $67.99 | $952.7K | -$47.22M | 19 | 2025-12-18 |
| Akero Therapeutics, Inc. (AKRO) Delisted | Director | 0 | $54.65 | $0 | $3.48M | 6 | 2021-06-03 |
| EDIT | Director | 2,797,144 | $2.50 | $6.99M | -$31.19M | 10 | 2017-06-19 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | 1,374,561 | $0.00 | $825 | $2.79M | 3 | 2016-06-07 |
Recent Filings · Page 3 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-03 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −17,489 | -$459.6K | EDGAR |
| 2020-10-14 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −13,000 | -$376.1K | EDGAR |
| 2020-06-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-25 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | +3,974,858 | $4.32M | EDGAR |
| 2017-06-19 | EDIT | Grant (A) | — | $0 | EDGAR |
| 2017-05-24 | EDIT | Sell (S) | −1,000,000 | -$17.00M | EDGAR |
| 2016-12-08 | EDIT | Sell (S) | −75,000 | -$1.19M | EDGAR |
| 2016-12-07 | EDIT | Sell (S) | −130,000 | -$2.05M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.